pentoxifylline has been researched along with Cicatrization in 5 studies
Cicatrization: The formation of fibrous tissue in the place of normal tissue during the process of WOUND HEALING. It includes scar tissue formation occurring in healing internal organs as well as in the skin after surface injuries.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate the efficiency of pentoxifylline (PTX), a methyl xanthine derivative, in preventing renal scar formation after the induction of pyelonephritis in an experimental rat model with delayed antimicrobial therapy." | 7.72 | Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. ( Boleken, ME; Dindar, H; Ertoy, D; Gokcora, IH; Ozsan, M; Yagmurlu, A, 2003) |
"Pentoxifylline has been used to treat various dermatological conditions including peripheral vascular disease, vasculitis and vasculopathies, chilblains, pigmented purpuric dermatosis, granuloma annulare, necrobiosis, keloids, lichen sclerosis et atrophicus, scars, radiation-induced fibrosis, vitiligo, alopecia areata, leishmaniasis, and leprosy." | 5.41 | Pentoxifylline in dermatology. ( Axler, E; Balazic, E; Khanna, U; Kobets, K; Konisky, H, 2023) |
"To evaluate the efficiency of pentoxifylline (PTX), a methyl xanthine derivative, in preventing renal scar formation after the induction of pyelonephritis in an experimental rat model with delayed antimicrobial therapy." | 3.72 | Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. ( Boleken, ME; Dindar, H; Ertoy, D; Gokcora, IH; Ozsan, M; Yagmurlu, A, 2003) |
"Pyoderma gangrenosum is most commonly treated with immunosuppressants or anti-inflammatory agents and is often worsened by surgical procedures due to the presence of pathergy." | 1.48 | Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid. ( Gordon, C; Hizon, BJ; Mota, JA; Nahm, WJ; Rojas, S, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Balazic, E | 1 |
Axler, E | 1 |
Konisky, H | 1 |
Khanna, U | 1 |
Kobets, K | 1 |
Nahm, WJ | 1 |
Mota, JA | 1 |
Rojas, S | 1 |
Hizon, BJ | 1 |
Gordon, C | 1 |
Yagmurlu, A | 1 |
Boleken, ME | 1 |
Ertoy, D | 1 |
Ozsan, M | 1 |
Gokcora, IH | 1 |
Dindar, H | 1 |
Dans, MJ | 1 |
Isseroff, R | 1 |
Saika, S | 1 |
Yamanaka, O | 1 |
Okada, Y | 1 |
Tanaka, S | 1 |
Ohnishi, Y | 1 |
Ooshima, A | 1 |
1 review available for pentoxifylline and Cicatrization
Article | Year |
---|---|
Pentoxifylline in dermatology.
Topics: Cicatrix; Granuloma Annulare; Humans; Intermittent Claudication; Pentoxifylline; Vasculitis | 2023 |
4 other studies available for pentoxifylline and Cicatrization
Article | Year |
---|---|
Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.
Topics: Adult; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Chronic Disease; Cicatrix; Clobetasol | 2018 |
Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis.
Topics: Acute Disease; Animals; Cicatrix; Disease Models, Animal; Escherichia coli; Escherichia coli Infecti | 2003 |
Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma.
Topics: Cell Division; Cell Survival; Cells, Cultured; Cicatrix; Collagen; Dose-Response Relationship, Drug; | 1994 |
Pentoxifylline and pentifylline inhibit proliferation of human Tenon's capsule fibroblasts and production of type-I collagen and laminin in vitro.
Topics: Adult; Cell Division; Cells, Cultured; Cicatrix; Collagen; Connective Tissue; Connective Tissue Cell | 1996 |